Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Nuvion enters phase II trial in steroid-refractory graft-versus-host disease

March 14, 2002

PowderJect submits MAA for Dukoral cholera and travel diarrhea vaccine

March 13, 2002

Synt:em licenses Pep:trans technology to Corixa for vaccine development

March 13, 2002

AtheroGenics begins phase I trial of transplant rejection drug AGI-1096

March 8, 2002

B7 protein PD-L2 described in patent

March 6, 2002

OrBec receives orphan drug status in Europe for intestinal graft-vs.-host disease

March 4, 2002

Effects on dendritic cell function of the immunomodulator R-848

March 4, 2002

Avant signs research agreement with International Vaccine Institute for cholera vaccine

Feb. 25, 2002

Nongenotoxic porphyrin derivatives from Eukarion effective as ROS catalytic scavengers

Feb. 22, 2002

Cholera vaccines offered for licensing by NIH

Feb. 20, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026